0.8039
0.22%
-0.0018
시간 외 거래:
.84
0.0361
+4.49%
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
47.98%
37.29
|
25.20 | 27.21 | 25.80 | 29.30 |
Interest Income/Expense |
0.64%
1.874
|
1.886 | 1.634 | 1.148 | 1.109 |
Operating Income/Loss |
47.98%
-37.29
|
-25.20 | -27.21 | -25.80 | -29.30 |
Nonoperating Income/Loss |
336.94%
-14.46
|
6.102 | 24.93 | -29.89 | 5.288 |
Income/Loss From Continuing Operations Before Tax |
170.97%
-51.75
|
-19.10 | -2.279 | -55.70 | -24.02 |
Income Tax Expense/Benefit |
42.42%
0.019
|
0.033 | 0.026 | 0.015 | 0.004 |
Income/Loss From Continuing Operations After Tax |
170.60%
-51.77
|
-19.13 | -2.305 | -55.71 | -24.02 |
Net Income/Loss
|
170.60%
-51.77
|
-19.13 | -2.305 | -55.71 | -24.02 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,732%
199.99
|
7.0615 | 196.99 | 168.74 | 145.97 |
Diluted Average Shares |
2,732%
199.99
|
7.0615 | 196.99 | 168.74 | 145.97 |
Basic Earnings Per Share |
188.89%
-0.26
|
-0.09 | -0.01 | -0.33 | -0.16 |
Diluted Earnings Per Share |
188.89%
-0.26
|
-0.09 | -0.01 | -0.33 | -0.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):